The Efficacy and Safety of Tyrosine Kinase Inhibitors for Von Hippel–Lindau Disease: A Retrospective Study of 32 Patients

Overview of attention for article published in Frontiers in oncology, November 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 23,019 followers.

RT @VHLANZ: Frontiers | The Efficacy and Safety of Tyrosine Kinase Inhibitors for Von Hippel–Lindau Disease: A Retrospective Study of 32 Pa…

RT @VHLANZ: Frontiers | The Efficacy and Safety of Tyrosine Kinase Inhibitors for Von Hippel–Lindau Disease: A Retrospective Study of 32 Pa…

RT @VHLANZ: Frontiers | The Efficacy and Safety of Tyrosine Kinase Inhibitors for Von Hippel–Lindau Disease: A Retrospective Study of 32 Pa…

RT @VHLANZ: Frontiers | The Efficacy and Safety of Tyrosine Kinase Inhibitors for Von Hippel–Lindau Disease: A Retrospective Study of 32 Pa…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.